Canadian Food Inspection Agency Canada
Français Contact Us Help Search Canada Site
Home What's New Acts and Regulations Site Map
Food Safety Animal Health Plant Protection Corporate Affairs

bullet Main Page - Animal Products
bullet Main Page - Feeds
bullet Acts and Regulations
bullet Approved Feed Ingredients
- Schedule IV Part 1
- Schedule IV Part 2
- Schedule V Part 1
- Schedule V Part 2
bullet Feed Updates
bullet Trade Memoranda
bullet Registration Checklists
bullet Compendium of Medicating Ingredient Brochures
bullet Novel Feeds
bullet Contacts

Animals > Livestock Feeds > Compendium of Medicating Ingredient Brochures  

NARASIN

MIB #73


Approved Brands: MONTEBAN 70 PREMIX contains narasin at 70 g/kg (Elanco)
Approved for use: In meal or pellet feed for broiler chickens and growing-finishing swine
Approved claims: For broiler chickens - Claim 1, 2
For growing-finishing swine - Claim 3

Claim 1: As an aid in the prevention of Coccidiosis in broiler chickens caused by Eimeria acervulina, Eimeria brunetti, Eimeria maxima, Eimeria necatrix, Eimeria tenella, and Eimeria mitis in broiler chickens.
Level of Drug: 70 mg/kg (0.0070%) of the complete feed.
Directions: Feed this medicated feed continuously as the sole ration.
WARNING: 1. Do not feed to laying chickens.
CAUTION: 1. Do not allow canines, horses or other equines access to formulations containing narasin. Ingestion of narasin by these species has been fatal.
2. Poultry consuming narasin should not be treated with products containing tiamulin. Severe growth depression may occur.
3. Do not feed to turkeys.
4. In the absence of Coccidiosis, feeds containing in excess of 70 mg/kg narasin may reduce the performance of growing broiler chickens.
5. Do not use this medicated feed for the treatment of outbreaks of Coccidiosis.
6. Not to be used in feeds containing pellet binding agents with the exception of Basfin (0.03%) Lignosol (4%) and Bentonite (2%). (Required on premix and supplement labels only).
Claim 2: For the prevention of necrotic enteritis in broiler chickens
Level of Drug: 70 mg/kg (0.0070%) of the complete feed.
Directions: Feed this medicated feed continuously as the sole ration.
WARNING 1. Do not feed to laying chickens.
CAUTION: 1. Do not allow canines, horses or other equines access to formulations containing narasin. Ingestion of narasin by these species has been fatal.
2. Poultry consuming narasin should not be treated with products containing tiamulin. Severe growth depression may occur.
3. Do not feed to turkeys.
4. In the absence of Coccidiosis, feeds containing in excess of 70 mg/kg narasin may reduce the performance of growing broiler chickens.
5. Do not use this medicated feed for the treatment of outbreaks of Coccidiosis.
6. Not to be used in feeds containing pellet binding agents with the exception of Basfin (0.03%) Lignosol (4%) and Bentonite (2%). (Required on premix and supplement labels only).
Claim 3: For increased rate of weight gain and improved feed efficiency in growing and finishing swine.
Level of Drug: 15mg/kg (0.0015%) of the complete feed.
Directions: Feed this medicated feed continuously as the sole ration from 20 kg to market weight.
CAUTION: 1. Do not allow canines, horses or other equines access to formulations containing narasin. Ingestion of narasin by these species has been fatal.
2. Swine consuming narasin should not be treated with products containing tiamulin. Severe growth depression may occur.
3. Do not use in feeds for swine intended for breeding.
4. Do not feed to turkeys.
5. Not to be used in feeds containing pellet binding agents with the exception of Basfin (0.03%), Lignosol (4%) and Bentonite (2%). (Required on premix and supplement labels only).

Accepted Compatibilities: Narasin is compatible with the following drugs. For further details refer to the MIB as indicated.
  for use in feed for
1. 3-Nitro-4-Hydroxyphenylarsonic Acid (MIB # 21) Broiler chickens
2. Virginiamycin (MIB #10.11) Broiler chickens
3. Bacitracin methylene disalicylate (MIB #48) Broiler chickens

CMIB Table of Contents



Top of Page
Top of Page
Important Notices